Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: A case report for a cancer of unknown primary origin
Pedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, Elvira An, Nicole Simms, Melanie Galvin, Hui Sun Leong, Kristopher K. Frese, Kathryn Simpson, Natalie Cook, Andrew Hughes, Crispin J. Miller, Richard Marais, Caroline Dive, Matthew G. Krebs, John Brognard
Research output: Contribution to journal › Article › peer-review
6Scopus
citations
Fingerprint
Dive into the research topics of 'Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: A case report for a cancer of unknown primary origin'. Together they form a unique fingerprint.